Healthcare Settings
The use of TBS’ technology to disinfect healthcare spaces, such as patient
rooms, will provide for a more thorough and complete disinfection than
that achieved by the use of liquid disinfectants applied manually. TBS will
replace existing chemicals used, and will virtually eliminate labor previously
associated with the application of liquid disinfectants. The CDC has estimated
that 2,000,000 hospital patients become infected during their hospital stay
with a Hospital Acquired Infection (HAI) such as MRSA (also known as the “super
bug”).
Of those infected it is estimated that 88,000 die each year. Such infections
are not limited to hospitals, but are seen in all healthcare settings,
and are also seen outside of healthcare in schools, athletic facilities
etc., where such infections are known as Community Acquired Infections.
Controlled Environments
Pharmaceutical, biotechnology and other facilities have numerous controlled
environments, such as isolators and bio safety cabinets, which require
periodic disinfection. TBS' technology can provide high level disinfection
of such spaces with a minimum of downtime and labor.
Other Applications
TBS has identified other applications such as cruise lines, food preparation,
hotels, child care, public transportation, airlines, department of defense, homeland
security and others who all have disinfection needs that TBS can successfully
address and improve on current disinfection methods.
Breakthrough Technology
We develop products, based on patent-pending proprietary technology,
that rapidly generate and deliver chlorine dioxide gas or gas in an aqueous
solution at point-of-need, allowing small scale applications to benefit
from chlorine dioxide for the first time. The Company has successfully
conducted efficacy tests. The Company expects to establish strategic
partnerships with sales and distribution leaders in target markets to
accelerate market penetration in multiple markets. TBS plans to be the
leader in the use of chlorine dioxide for disinfection of healthcare
settings and laboratory spaces.
TBS Technologies breakthrough technology will provide a better
and more thorough way to disinfect spaces, including controlled environments
and healthcare spaces.
Independent testing has demonstrated up to 99.9999% (6 log)
kills of target organisms.
TBS’ patent pending technology provides
a unique way to generate chlorine dioxide on site at the point-of-need,
rapidly, automatically and easy.
TBS’ “plug’n’play” modality requires
no skilled labor to operate.
To use: Place in the space to be disinfected, insert
the disposable “cassette” and turn on – it’s
simple.
Chlorine dioxide, long recognized as a superior disinfectant chemical,
has been registered by the USEPA for 40 years for a wide variety of uses.
TBS did not invent chlorine dioxide – TBS invented a practical
way for the superior power of chlorine dioxide to be used for small applications.
TBS has assembled a management team and business and scientific advisory
boards with extensive relevant experience and a track record of business
success.
Efficacy
Independent testing has demonstrated the ability of TBS to achieve high level
disinfection 99.9999% (6 log reduction) on a variety of target organisms. |
